Clinical classification systems and long-term outcome in mid- and late-stage Parkinson's disease.
Journal
NPJ Parkinson's disease
ISSN: 2373-8057
Titre abrégé: NPJ Parkinsons Dis
Pays: United States
ID NLM: 101675390
Informations de publication
Date de publication:
02 Aug 2021
02 Aug 2021
Historique:
received:
12
01
2021
accepted:
01
07
2021
entrez:
3
8
2021
pubmed:
4
8
2021
medline:
4
8
2021
Statut:
epublish
Résumé
Parkinson's disease shows a heterogeneous course and different clinical subtyping systems have been described. To compare the capabilities of two clinical classification systems, motor-phenotypes, and a simplified clinical motor-nonmotor subtyping system, a cohort was included at mean 7.9 ± 5.3 years of disease duration, classified using both clinical systems, and reexamined and reclassified at the end of an observation period. Time-points were retrospectively extracted for five major disease milestones: death, dementia, Hoehn and Yahr stage 5, nursing home living, and walking aid use. Eighty-nine patients were observed for 8.1 ± 2.7 years after inclusion. Dementia developed in 32.9% of the patients and 36.0-67.4% reached the other milestones. Motor-phenotypes were unable to stratify risks during this period, but the worst compared with the more favorable groups in the motor-nonmotor system conveyed hazard ratios between 2.6 and 63.6 for all milestones. A clear separation of risks for dying, living at the nursing home, and reaching motor end-stage was also shown when using only postural instability and gait disorder symptoms, without weighing them against the severity of the tremor. At reexamination, 29.4% and 64.7% of patients had changed classification groups in the motor-phenotype and motor-nonmotor systems, respectively. The motor-nonmotor system thus stratified risks of reaching crucial outcomes in mid-late Parkinson's disease far better than the well-studied motor-phenotypes. Removing the tremor aspect of motor-phenotypes clearly improved this system, however. Classifications in both systems became unstable over time. The simplification of the motor-nonmotor system was easily applicable and showed potential as a prognostic marker during a large part of Parkinson's disease.
Identifiants
pubmed: 34341343
doi: 10.1038/s41531-021-00208-4
pii: 10.1038/s41531-021-00208-4
pmc: PMC8329298
doi:
Types de publication
Journal Article
Langues
eng
Pagination
66Informations de copyright
© 2021. The Author(s).
Références
Mov Disord. 2019 Jun;34(6):876-883
pubmed: 30869825
Parkinsonism Relat Disord. 2015 May;21(5):431-43
pubmed: 25737398
Mov Disord. 2016 Jul;31(7):957-61
pubmed: 27226220
Front Neurol. 2020 Jul 07;11:548
pubmed: 32733352
Parkinsonism Relat Disord. 2016 Jul;28:62-7
pubmed: 27132498
Neurology. 1990 Oct;40(10):1529-34
pubmed: 2215943
Mov Disord. 2006 Jul;21(7):916-23
pubmed: 16547944
J Parkinsons Dis. 2015;5(2):269-79
pubmed: 26405788
Parkinsonism Relat Disord. 2015 Jul;21(7):675-82
pubmed: 25952959
JAMA Neurol. 2015 Aug;72(8):863-73
pubmed: 26076039
Parkinsonism Relat Disord. 2020 Apr;73:31-34
pubmed: 32224439
Sleep Med Rev. 2018 Oct;41:101-112
pubmed: 29449121
J Parkinsons Dis. 2015;5(2):313-9
pubmed: 25720446
Lancet Neurol. 2017 Nov;16(11):908-916
pubmed: 28958801
Eur J Neurosci. 2019 Feb;49(3):328-338
pubmed: 30059179
JAMA Neurol. 2019 Apr 1;76(4):470-479
pubmed: 30640364
Front Aging Neurosci. 2017 Sep 20;9:301
pubmed: 28979203
Brain. 2010 Jun;133(Pt 6):1755-62
pubmed: 20371510
J Neurol Neurosurg Psychiatry. 2013 Nov;84(11):1258-64
pubmed: 23781007
Neuroimage Clin. 2020;25:102111
pubmed: 31855654
J Clin Neurosci. 2019 May;63:142-148
pubmed: 30732989
Mov Disord. 2006 Aug;21(8):1123-30
pubmed: 16637023
Lancet Neurol. 2015 Jan;14(1):57-64
pubmed: 25435387
Neurology. 2016 Jun 14;86(24):2243-50
pubmed: 27178702
Parkinsonism Relat Disord. 2018 Nov;56:102-106
pubmed: 30056038
Parkinsonism Relat Disord. 2019 Aug;65:178-183
pubmed: 31255537
Ann Neurol. 2014 Oct;76(4):469-72
pubmed: 25164235
Front Neuroendocrinol. 2018 Jul;50:18-30
pubmed: 28974386
Parkinsonism Relat Disord. 2016 Jul;28:137-40
pubmed: 27158121
Neuroimage Clin. 2019;24:101986
pubmed: 31514113
Parkinsonism Relat Disord. 2011 Sep;17(8):579-86
pubmed: 21489852
Nat Rev Neurol. 2017 Aug;13(8):454-455
pubmed: 28685759
Brain. 2017 Jul 1;140(7):1959-1976
pubmed: 28549077
Mov Disord. 2011 Jan;26(1):51-8
pubmed: 21322019
Mov Disord. 2014 Jan;29(1):150-1
pubmed: 24038593
Int Rev Neurobiol. 2017;133:447-478
pubmed: 28802928
J Neurol Neurosurg Psychiatry. 2018 Dec;89(12):1279-1287
pubmed: 30464029
Mov Disord. 2008 Apr 30;23(6):837-44
pubmed: 18307261
Neurology. 2016 Jul 12;87(2):168-77
pubmed: 27164658
J Neurol Neurosurg Psychiatry. 2012 Jun;83(6):607-11
pubmed: 22362919